117 related articles for article (PubMed ID: 15648574)
1. Oral administration of biochemically active microcapsules to treat uremia: new insights into an old approach.
O'Loughlin JA; Bruder JM; Lysaght MJ
J Biomater Sci Polym Ed; 2004; 15(11):1447-61. PubMed ID: 15648574
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro degradation of urea and uric acid by encapsulated genetically modified microorganisms.
O'Loughlin JA; Bruder JM; Lysaght MJ
Tissue Eng; 2004; 10(9-10):1446-55. PubMed ID: 15588404
[TBL] [Abstract][Full Text] [Related]
3. Degradation of low molecular weight uremic solutes by oral delivery of encapsulated enzymes.
O'Loughlin JA; Bruder JM; Lysaght MJ
ASAIO J; 2004; 50(3):253-60. PubMed ID: 15171478
[TBL] [Abstract][Full Text] [Related]
4. An orally administered microcapsule system for treating chronic renal failure patients.
Gardner DL; Kjellstrand CM; Hassler CR; Fink DJ; Emmerling DC
Appl Biochem Biotechnol; 1984; 10():27-40. PubMed ID: 6524933
[TBL] [Abstract][Full Text] [Related]
5. Oral microencapsulated live Saccharomyces cerevisiae cells for use in renal failure uremia: preparation and in vivo analysis.
Coussa R; Martoni C; Bhathena J; Urbanska AM; Prakash S
J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20798777
[TBL] [Abstract][Full Text] [Related]
6. Nitrogen metabolism in the gut.
Wrong O
Am J Clin Nutr; 1978 Sep; 31(9):1587-93. PubMed ID: 685874
[TBL] [Abstract][Full Text] [Related]
7. The promise of enzymes in therapy of uremia. III. Enzyme preparation.
Setälä K
Nephron; 1984; 37(1):12-20. PubMed ID: 6717699
[No Abstract] [Full Text] [Related]
8. An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure.
Zheng DW; Pan P; Chen KW; Fan JX; Li CX; Cheng H; Zhang XZ
Nat Biomed Eng; 2020 Sep; 4(9):853-862. PubMed ID: 32632226
[TBL] [Abstract][Full Text] [Related]
9. Binders to remove uremic waste metabolites from the GI tract.
Sparks RE; Mason NS; Meier PM; Samuels WE; Litt MH; Lindan O
Trans Am Soc Artif Intern Organs; 1972; 18(0):458-64, 484. PubMed ID: 4679903
[No Abstract] [Full Text] [Related]
10. Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats.
Prakash S; Chang TM
Nat Med; 1996 Aug; 2(8):883-7. PubMed ID: 8705857
[TBL] [Abstract][Full Text] [Related]
11. Microencapsulated genetically engineered E. coli DH5 cells for plasma urea and ammonia removal based on: 1. Column bioreactor and 2. Oral administration in uremic rats.
Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1996 May; 24(3):201-18. PubMed ID: 8773740
[TBL] [Abstract][Full Text] [Related]
12. Removal of uremic waste metabolites from the intestinal tract by encapsulated carbon and oxidized starch.
Sparks RE; Mason NS; Meier PM; Litt MH; Lindan O
Trans Am Soc Artif Intern Organs; 1971; 17():229-38. PubMed ID: 5158097
[No Abstract] [Full Text] [Related]
13. Biochemistry of renal failure.
Wills MR; Savory J
Ann Clin Lab Sci; 1981; 11(4):292-9. PubMed ID: 7023344
[TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
15. [Intestinal elimination of uremic metabolites by the adsorbents].
Drüeke T
Med Klin; 1976 Jan; 71(3):87-93. PubMed ID: 233947
[No Abstract] [Full Text] [Related]
16. Bowel as a kidney substitute in renal failure.
Friedman EA
Am J Kidney Dis; 1996 Dec; 28(6):943-50. PubMed ID: 8957051
[TBL] [Abstract][Full Text] [Related]
17. Continuous intestinal dialysis for uraemia by intermittent oral intake of non-absorbable solutions. An experimental study.
Miskowiak J
Scand J Urol Nephrol; 1991; 25(1):71-4. PubMed ID: 1904625
[TBL] [Abstract][Full Text] [Related]
18. Growth and survival of renal failure rats that received oral microencapsulated genetically engineered E. coli DH5 cells for urea removal.
Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1998 Jan; 26(1):35-51. PubMed ID: 9507755
[TBL] [Abstract][Full Text] [Related]
19. Bacterial enzymes in uremia management.
Setälä K
Kidney Int Suppl; 1978 Jun; (8):S194-202. PubMed ID: 278891
[TBL] [Abstract][Full Text] [Related]
20. Studies on doxycycline during intravenous and oral treatment with reference to renal function.
Alestig K
Scand J Infect Dis; 1973; 5(3):193-8. PubMed ID: 4767570
[No Abstract] [Full Text] [Related]
[Next] [New Search]
